Проект «Relink» — возвращение пациентов к медицинскому обслуживанию.

The CDA Foundation invites patient‑advocacy groups, public health agencies, clinicians, and researchers to a focused one‑day symposium that will spotlight the fourth round of the Relink Project—an initiative designed to re‑engage “diagnosed but untreated” (DBU) hepatitis B and C patients and guide them back into specialist care. Attendees will hear directly from CDAF leadership about the program’s core goals, funding structure (grants ranging from $20 K to a $250 K cap with an average award of $100‑120 K), eligibility criteria, and the legal framework that underpins each partnership—including the binding Agreement & DUA. Interactive sessions will walk participants through the complete application pipeline—grant proposal development, budget and timeline planning, and data‑management requirements (REDCap imports, Epic extraction templates, or alternative registries). Practical guidance on structuring patient‑navigator roles, leveraging indirect costs, and forming strategic alliances with state health agencies will be provided to maximize impact while staying within cost‑per‑individual benchmarks.

Beyond the mechanics of funding, the symposium will showcase proven re‑engagement models through case studies such as Helen Nde’s “Best Practices to Reengage Lost Hep B Patients” and recent CDAF research on hepatitis‑B vaccine safety. Panels will explore how to define “linked to care,” navigate multi‑institution collaborations, and address common operational questions—from handling supplies and equipment to ensuring compliance with IRB policies when publishing outcomes. By the close of the event, participants will leave equipped with a clear roadmap for submitting competitive proposals, building robust data pipelines, and ultimately delivering measurable improvements in liver‑health outcomes across their communities.